Russia starts large-scale trials of third COVID-19 vaccine

MOSCOW: Russia's Chumakov Center has started phase three trials of CoviVac, Russia's third vaccine against COVID-19, the Interfax news agency cited a government minister as saying on Thursday.

The most well known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two others, EpiVacCorona and CoviVac.